Volume 65, Issue 6, Pages (June 2004)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

A.M. Thompson, T.G. Pickering Kidney International

Volume 77, Issue 12, Pages (June 2010)

Beta blockers in the management of chronic kidney disease

Volume 69, Issue 11, Pages (June 2006)

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Volume 66, Issue 4, Pages (October 2004)

Volume 63, Issue 1, Pages (January 2003)

Volume 63, Issue 6, Pages (June 2003)

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 61, Issue 2, Pages (February 2002)

Reassessment of the care of the patient with chronic kidney disease

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Burden of chronic kidney disease: North Africa

Volume 56, Issue 2, Pages (August 1999)

Francesco Paolo Schena Kidney International

Volume 57, Pages S74-S81 (January 2000)

Volume 70, Pages S21-S25 (December 2006)

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 81, Issue 11, Pages (June 2012)

Comorbidity and confounding in end-stage renal disease

Volume 64, Issue 1, Pages (July 2003)

Volume 68, Issue 1, Pages (July 2005)

Volume 70, Issue 11, Pages (December 2006)

Manjula Kurella Tamura, Kristine Yaffe Kidney International

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Volume 64, Issue 5, Pages (November 2003)

Volume 85, Issue 1, Pages (January 2014)

Fructose intake as a risk factor for kidney stone disease

Volume 54, Issue 3, Pages (September 1998)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Alternate-day dialysis may be needed for hemodialysis patients

Hepatitis C treatment in patients with kidney disease

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

David A. Goodkin, MD, Eric W

Volume 81, Issue 9, Pages (May 2012)

Prehypertension: is it relevant for nephrologists?

Peritoneal dialysis in Mexico

Volume 63, Issue 6, Pages (June 2003)

Current status of maintenance hemodialysis in Beijing, China

Volume 95, Issue 4, Pages (April 2019)

Low triiodothyronine and survival in end-stage renal disease

Volume 65, Issue 6, Pages (June 2004)

Volume 61, Issue 1, Pages (January 2002)

The Iranian model of living renal transplantation

Is complement a target for therapy in renal disease?

Renal replacement therapy in Latin America

Volume 75, Issue 7, Pages (April 2009)

Changes to the End-Stage Renal Disease Quality Incentive Program

Volume 77, Issue 12, Pages (June 2010)

Volume 70, Issue 10, Pages (November 2006)

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Volume 87, Issue 6, Pages (June 2015)

Volume 69, Issue 7, Pages (April 2006)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 65, Issue 6, Pages 2335-2342 (June 2004) Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS Rachel B. Fissell, Jennifer L. Bragg-Gresham, John D. Woods, Michel Jadoul, Brenda Gillespie, Sara A. Hedderwick, Hugh C. Rayner, Roger N. Greenwood, Takashi Akiba, Eric W. Young Kidney International Volume 65, Issue 6, Pages 2335-2342 (June 2004) DOI: 10.1111/j.1523-1755.2004.00649.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Variation in hepatitis C virus (HCV) prevalence by patient's time with end-stage renal disease (ESRD). The mean time on ESRD was 4.9years, with a standard deviation of 5.4years. Kidney International 2004 65, 2335-2342DOI: (10.1111/j.1523-1755.2004.00649.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Distribution of hepatitis C virus (HCV) prevalence by facility. Mean HCV prevalence was 13.5%, with a median of 10.5%. The percentage of facilities with an HCV prevalence of 0% to 5% was 26.6%. Kidney International 2004 65, 2335-2342DOI: (10.1111/j.1523-1755.2004.00649.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Distribution of hepatitis C virus (HCV) seroconversion rates by facility. In 55.6% of facilities, the mean seroconversion rate was 0 seroconversions per 100 patient-years. Kidney International 2004 65, 2335-2342DOI: (10.1111/j.1523-1755.2004.00649.x) Copyright © 2004 International Society of Nephrology Terms and Conditions